SECsense Logo

Revelation Biosciences, Inc. 8-K Report: Key Financial Insights and Securities Update

$REVB
Form 8-K
Filed on: 2025-01-07
Source
Revelation Biosciences, Inc. 8-K Report: Key Financial Insights and Securities Update

Based on the provided excerpt from the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Revelation Biosciences, Inc.
  • CIK: 0001810560
  • Incorporation: Delaware (DE)
  • SEC File Number: 001-39603
  • EIN: 84-3898466
  • Address: 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122
  • Contact: (650) 800-3717
  1. Report Type and Date:
  • Filing Type: 8-K (Current Report)
  • Filing Date: January 3, 2025
  1. Securities Information:
  • Common Stock:
    • Par Value: $0.001 per share
    • Ticker Symbol: REVB (NASDAQ)
  • Redeemable Warrants:
    • Each warrant is exercisable for a 1/1,050th share of common stock.
    • Exercise Price: $12,075.00 per share
    • Ticker Symbol: REVBW (NASDAQ)
  1. Contextual Information:
  • The report covers a specific date: January 3, 2025, which suggests that it may relate to a significant event or transaction occurring on that date.
  • The segments mentioned are related to the classes of stock, specifically focusing on redeemable warrants and common stock.
  1. Implications:
  • The high exercise price of the redeemable warrants ($12,075) suggests a potential capital-raising mechanism that may involve significant investment.
  • The filing of an 8-K indicates that the company may be disclosing important corporate events, which can impact stock performance and investor sentiment.

In summary, this section of the financial report provides essential details about Revelation Biosciences, Inc.'s current securities and their characteristics, along with filing details that indicate active corporate governance and compliance with SEC regulations.